Is a complete CELZ research report available?

No complete published report is available for Creative Medical Technology Holdings, Inc. (CELZ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Creative Medical Technology Holdings, Inc. (CELZ)

NASDAQ: CELZ · USD

$0.71

+0.02 (+3.2%)· Recorded snapshot

Market cap	4.7M
Revenue (ttm)	3K
Net income (ttm)	-6M
EPS (ttm)	-$1.95
Shares out	6.6M
Volume	90,323
Beta	1.90

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3K
Net income (ttm): -6M
EPS (ttm): -$1.95
Market cap: 4.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001187953
Company name	Creative Medical Technology Holdings, Inc.
Country	United States
Country code	US
CUSIP number	22529Y408
Earnings date	2026-11-10
Earnings time	amc
Employees	4
Employees change	0
Employees growth	0%
Enterprise value	$-4.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US22529Y4089
Last 10-K release date	2026-03-20
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Last stock split date	2023-06-12
Last stock split type	Reverse
Market cap	$4.7M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$0.71
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CELZ
U.S. state	Arizona
Website	https://www.creativemedicaltechnology.com

Metric

Value

Amount currency

USD

CIK code

0001187953

Company name

Creative Medical Technology Holdings, Inc.

Country

United States

Country code

CUSIP number

22529Y408

Earnings date

2026-11-10

Earnings time

amc

Employees

Employees change

Employees growth

Enterprise value

$-4.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1998

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US22529Y4089

Last 10-K release date

2026-03-20

Last earnings date

2026-08-07

Last refreshed

2026-10-28

Last stock split date

2023-06-12

Last stock split type

Reverse

Market cap

$4.7M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Price

$0.71

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CELZ

U.S. state

Arizona

Website

https://www.creativemedicaltechnology.com

Metric	Value
Earnings yield	-274.34%
FCF / EV yield	140.73%
FCF yield	-127.43%
P/B ratio	0.52x
P/S ratio	1,543.76x
Price / tangible book value	0.56x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-274.34%

FCF / EV yield

140.73%

FCF yield

-127.43%

P/B ratio

0.52x

P/S ratio

1,543.76x

Price / tangible book value

0.56x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	66.87%
Operating margin	-208,004.4%
Pretax margin	-201,285.83%
Profit per employee	$-1.5M
Revenue per employee	$750
ROA	-47.32%
ROA (5Y)	-38.5%
ROCE	-71.9%
ROE	-77.88%
ROIC	-50.21%

Metric

Value

Gross margin

66.87%

Operating margin

-208,004.4%

Pretax margin

-201,285.83%

Profit per employee

$-1.5M

Revenue per employee

$750

ROA

-47.32%

ROA (5Y)

-38.5%

ROCE

-71.9%

ROE

-77.88%

ROIC

-50.21%

Metric	Value
EPS growth quarters	5
EPS growth years	3
Gross profit growth	-44.28%
Gross profit growth 3Y	-66.19%
Gross profit growth 5Y	-51.45%
Net income growth years	0
Revenue growth	-50%
Revenue growth 3Y	-65.59%
Revenue growth 5Y	-50.84%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-44.28%

Gross profit growth 3Y

-66.19%

Gross profit growth 5Y

-51.45%

Net income growth years

Revenue growth

-50%

Revenue growth 3Y

-65.59%

Revenue growth 5Y

-50.84%

Revenue growth years

Metric	Value
Depreciation and amortization	$113,781
EBIT	$-6.2M
EBITDA	$-6.1M
EPS	$-1.95
FCF per share	$-0.90
Financing cash flow	$8.3M
Free cash flow	$-5.9M
Gross profit	$2,006
Investing cash flow	$-225,500
Net cash flow	$2.2M
Net income	$-6M
Operating income	$-6.2M
Revenue	$3,000

Metric

Value

Depreciation and amortization

$113,781

EBIT

$-6.2M

EBITDA

$-6.1M

EPS

$-1.95

FCF per share

$-0.90

Financing cash flow

$8.3M

Free cash flow

$-5.9M

Gross profit

$2,006

Investing cash flow

$-225,500

Net cash flow

$2.2M

Net income

$-6M

Operating income

$-6.2M

Revenue

$3,000

Metric	Value
Altman Z-Score	-4.46
Book value per share	$1.33
Debt / equity	0
Long-term assets	$358,740
Long-term liabilities	$0
Net cash (debt)	$8.8M
Net cash / market cap	190.55%
Net cash growth	35.15%
Net debt / equity	-1.02
Piotroski F-Score	2
Shareholders' equity	$8.7M
Tangible book value	$8.3M
Tangible book value per share	$1.28
Total assets	$9.4M
Total cash	$8.8M
Total debt	$14,194
Total liabilities	$698,595
WACC	14.68%

Metric

Value

Altman Z-Score

-4.46

Book value per share

$1.33

Debt / equity

Long-term assets

$358,740

Long-term liabilities

Net cash (debt)

$8.8M

Net cash / market cap

190.55%

Net cash growth

35.15%

Net debt / equity

-1.02

Piotroski F-Score

Shareholders' equity

$8.7M

Tangible book value

$8.3M

Tangible book value per share

$1.28

Total assets

$9.4M

Total cash

$8.8M

Total debt

$14,194

Total liabilities

$698,595

WACC

14.68%

Metric	Value
Asset turnover	0
Current assets	$9M
Current liabilities	$698,595
Current ratio	12.91
Net working capital	$-504,603
Quick ratio	12.65
Working capital	$8.3M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$9M

Current liabilities

$698,595

Current ratio

12.91

Net working capital

$-504,603

Quick ratio

12.65

Working capital

$8.3M

Working capital turnover

Metric	Value
Buyback yield / dilution	-61.5%
Dividend yield	0%
Shareholder yield	-61.5%

Metric

Value

Buyback yield / dilution

-61.5%

Dividend yield

Shareholder yield

-61.5%

Metric	Value
10Y price change	-100%
10Y return CAGR	-73.29%
10Y total return	-100%
150-day SMA	$1.48
1D price change	3.16%
1M price change	-31.33%
1M total return	-31.33%
1W price change	-4.73%
1W total return	-4.73%
1Y price change	-86.25%
1Y return CAGR	-86.27%
1Y total return	-86.25%
20-day SMA	$0.81
200-day SMA	$1.59
3M price change	-10.84%
3M total return	-10.84%
3Y price change	-83.85%
3Y return CAGR	-45.54%
3Y total return	-83.85%
50-day SMA	$0.95
50-day SMA vs 200-day SMA	50under200
52-week high	$6.25
52-week high date	2025-10-28
52-week low	$0.62
52-week low date	2026-08-03
5Y price change	-99.04%
5Y return CAGR	-60.55%
5Y total return	-99.04%
6M price change	-68.98%
6M total return	-68.98%
All-time high	$525,013.13
All-time high date	2017-04-05
All-time low	$0.62
All-time low date	2026-08-03
Average true range (ATR)	$0.07
Average volume	107.6K
Beta (1Y)	5
Beta (2Y)	1.65
Beta (5Y)	1.9
Change from 52-week high	-88.61%
Change from 52-week low	14.84%
Change from all-time high	-100%
Change from all-time low	14.08%
Change from open	0%
Day's gap	3.16%
Dollar volume	$64,310
High price	$0.71
Low price	$0.71
Monthly RSI	33.24
Open price	$0.71
Premarket change	-0.01%
Premarket close	$0.69
Premarket price	$0.69
Previous close	$0.69
Price vs 150-day SMA	-52.18%
Price vs 20-day SMA	-12.31%
Price vs 200-day SMA	-55.49%
Price vs 50-day SMA	-25.67%
Relative volume	0.85
RSI	35.27
Sharpe ratio	-0.74
Sharpe ratio (3Y)	-0.03
Sharpe ratio (5Y)	-0.09
Sortino ratio	-1.22
Sortino ratio (3Y)	0.01
Sortino ratio (5Y)	-0.11
Volume	90.3K
Weekly RSI	33.99
YTD price change	-63.91%
YTD total return	-63.91%

Metric

Value

10Y price change

-100%

10Y return CAGR

-73.29%

10Y total return

-100%

150-day SMA

$1.48

1D price change

3.16%

1M price change

-31.33%

1M total return

-31.33%

1W price change

-4.73%

1W total return

-4.73%

1Y price change

-86.25%

1Y return CAGR

-86.27%

1Y total return

-86.25%

20-day SMA

$0.81

200-day SMA

$1.59

3M price change

-10.84%

3M total return

-10.84%

3Y price change

-83.85%

3Y return CAGR

-45.54%

3Y total return

-83.85%

50-day SMA

$0.95

50-day SMA vs 200-day SMA

50under200

52-week high

$6.25

52-week high date

2025-10-28

52-week low

$0.62

52-week low date

2026-08-03

5Y price change

-99.04%

5Y return CAGR

-60.55%

5Y total return

-99.04%

6M price change

-68.98%

6M total return

-68.98%

All-time high

$525,013.13

All-time high date

2017-04-05

All-time low

$0.62

All-time low date

2026-08-03

Average true range (ATR)

$0.07

Average volume

107.6K

Beta (1Y)

Beta (2Y)

1.65

Beta (5Y)

1.9

Change from 52-week high

-88.61%

Change from 52-week low

14.84%

Change from all-time high

-100%

Change from all-time low

14.08%

Change from open

Day's gap

3.16%

Dollar volume

$64,310

High price

$0.71

Low price

$0.71

Monthly RSI

33.24

Open price

$0.71

Premarket change

-0.01%

Premarket close

$0.69

Premarket price

$0.69

Previous close

$0.69

Price vs 150-day SMA

-52.18%

Price vs 20-day SMA

-12.31%

Price vs 200-day SMA

-55.49%

Price vs 50-day SMA

-25.67%

Relative volume

0.85

RSI

35.27

Sharpe ratio

-0.74

Sharpe ratio (3Y)

-0.03

Sharpe ratio (5Y)

-0.09

Sortino ratio

-1.22

Sortino ratio (3Y)

0.01

Sortino ratio (5Y)

-0.11

Volume

90.3K

Weekly RSI

33.99

YTD price change

-63.91%

YTD total return

-63.91%

Metric	Value
Float	6.6M
Float percentage	99.46%
Shares change (QoQ)	0%
Shares change (YoY)	61.5%
Shares held by insiders	0.19%
Shares held by institutions	9.14%
Shares outstanding	6.6M
Short % of float	1.25%
Short % of shares	1.24%
Short ratio	0.1 days

Metric

Value

Float

6.6M

Float percentage

99.46%

Shares change (QoQ)

Shares change (YoY)

61.5%

Shares held by insiders

0.19%

Shares held by institutions

9.14%

Shares outstanding

6.6M

Short % of float

1.25%

Short % of shares

1.24%

Short ratio

0.1 days

Creative Medical Technology Holdings, Inc. (CELZ)

Price

Financial snapshot

Fair-value bridge

Latest news · CELZ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CELZ indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CELZ

Frequently asked questions